68Ga-NOTA-RCCB6
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-NOTA-RCCB6, covering 2025-01-10 to 2025-01-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging [NA]